Can a Virginia resident get peptides by telehealth?
Virginia Code section 54.1-3303 requires a bona fide practitioner-patient relationship for every prescription: the practitioner must obtain a medical and drug history, discuss the benefits and risks of the treatment, perform an appropriate examination, and initiate follow-up care as needed. The statute allows the examination to be done by face-to-face interactive, two-way, real-time communication or by store-and-forward technologies when the standard of care does not require an in-person examination. Virginia classifies all prescription-only drugs that are not otherwise controlled as Schedule VI under the Drug Control Act, so GLP-1 medicines and prescription peptides fall within the Schedule II through VI telemedicine provisions of section 54.1-3303, which also expect the prescriber to maintain a practice location in Virginia or be able to make an appropriate referral. The prescriber must hold a Virginia license. Because the statute expressly names store-and-forward technologies, this record marks asynchronous prescribing as allowed, subject to the standard of care. [2] [3] [6]
How does the Virginia pharmacy board treat compounding?
| Board | Virginia Board of Pharmacy (Virginia Department of Health Professions) |
|---|---|
| Eligible substances | Adds state-specific limits to the 503A framework |
The Virginia Board of Pharmacy regulates pharmacies under the Drug Control Act (Virginia Code title 54.1, chapter 34) and regulations at 18VAC110-20; regulation 18VAC110-20-321 requires compounding to follow USP-NF compounding standards and section 54.1-3410.2. That statute allows compounding for specific patient prescriptions or in anticipation of prescriptions based on an observed prescribing pattern, and subsection F sets Virginia's own two-part test for bulk drug substances: the substance must meet an applicable USP or NF monograph (if one exists) and the USP compounding chapter, or be a component of an FDA approved drug, or be otherwise approved by FDA, or be made by an FDA-registered establishment; and it must come from a licensed or registered wholesale distributor or a supplier approved by the Board and FDA. Neither section 54.1-3410.2 nor 18VAC110-20-321 mentions the FDA 503A bulks list, so the state test does not turn on that list; federal 503A limits, including the bulks list, still apply to every Virginia compounder, and the state sourcing and USP requirements add to them. Section 54.1-3434.1 requires nonresident pharmacies to register, designate a pharmacist in charge licensed in Virginia, and submit a home-state inspection (within six months for a new registration, two years for renewal) showing USP compliance for compounding. [1] [4] [5] [7] [8] [9]
Can you get compounded GLP-1s in Virginia?
Out-of-state telehealth programs must dispense through a pharmacy registered under section 54.1-3434.1 with a Virginia-licensed pharmacist in charge. [4] [5] [12]
Prices by channel: semaglutide cost, tirzepatide cost.
Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.
What is the legal access path in Virginia?
Verified access options
Prescriber licensed in Virginia, in person or by telehealth
Telehealth prescribing of non-controlled peptides is permitted in Virginia. Asynchronous (questionnaire or messaging) prescribing is permitted when it meets the standard of care.
Check the dispensing pharmacy against the board's license lookup before paying, including out-of-state mail-order pharmacies.
Branded GLP-1 through a retail or manufacturer pharmacy
FDA approved semaglutide and tirzepatide are available by prescription. Compounded GLP-1 limited; see the GLP-1 section for why.
Access paths are verified against public regulatory records and prescriber licensing. We never list unlicensed vendors.
Find a provider in Virginia
Is it legal to buy research peptides in Virginia?
The Virginia Drug Control Act restricts the sale and dispensing of Schedule VI (prescription-only) drugs to licensed practitioners and permitted or registered pharmacies, so injectable peptides sold to Virginia consumers as "research use only" are outside the licensed supply chain. [1] [6] [13]
Peptide-specific notes for Virginia
| Peptide | Note |
|---|---|
| Semaglutide | A Schedule VI drug in Virginia, available branded by prescription, including after a real-time or store-and-forward telemedicine examination under section 54.1-3303. Compounded semaglutide is limited to the federal patient specific exception since the 503A grace period ended April 22, 2025. [3] [12] |
| BPC-157 | Not FDA approved and not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk; a state board cannot authorize what federal law does not. Virginia's own bulk substance criteria in section 54.1-3410.2 add a second hurdle. [4] [10] [11] |
Frequently asked questions
Can I get a GLP-1 prescription in Virginia through telemedicine?
Yes. Virginia Code section 54.1-3303 lets a Virginia-licensed prescriber establish a bona fide practitioner-patient relationship through real-time two-way communication or store-and-forward technology, as long as the standard of care does not require an in-person exam. The prescriber must still take a history, discuss risks and benefits, and arrange follow-up. [3]
Why does Virginia call GLP-1 drugs Schedule VI?
Virginia's Drug Control Act places every prescription-only drug that is not in Schedules I to V into Schedule VI. It does not mean the drug is a controlled substance in the federal sense; it simply means a prescription is required, and the telemedicine rules in section 54.1-3303 apply. [3] [6]
What does an out-of-state pharmacy need to ship compounded peptides to Virginia?
Registration as a nonresident pharmacy under section 54.1-3434.1, a pharmacist in charge licensed in Virginia, and a current home-state inspection report showing compliance with USP-NF standards for sterile and non-sterile compounding. The Department of Health Professions license lookup shows registration status. [1] [5]
Is compounded semaglutide or tirzepatide still available in Virginia?
Only in limited, patient specific cases. The FDA shortage allowances ended in 2025, and Virginia pharmacies must also meet the state's compounding statute, section 54.1-3410.2, so a GLP-1 can be compounded only for a documented need the approved product cannot meet. [4] [12]
Does Virginia have its own compounding law?
Yes. Section 54.1-3410.2 governs compounding in Virginia: it limits compounding to patient prescriptions or observed prescribing patterns, requires USP-NF compliance, sets bulk substance sourcing criteria, and regulates compounded products supplied for office administration. Federal 503A limits apply on top of it. [4] [9]
Sources
Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, and federal FDA guidance.
- [1]Virginia Board of Pharmacy (Department of Health Professions)
- [2]Virginia Board of Medicine (Department of Health Professions)
- [3]Virginia Code section 54.1-3303, Prescriptions to be issued and drugs to be dispensed for medical or therapeutic purposes only
- [4]Virginia Code section 54.1-3410.2, Compounding
- [5]Virginia Code section 54.1-3434.1, Nonresident pharmacies to register with Board
- [6]Virginia Code section 54.1-3455, Schedule VI
- [7]18VAC110-20, Regulations governing the practice of pharmacy
- [8]18VAC110-20-321, Compounding
- [9]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
- [10]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA
Cite this page
Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.
- APA style
PeptideAgent. (2026, September 22). Are peptides legal in Virginia?. https://peptideagent.ai/legal/virginia- HTML link
<a href="https://peptideagent.ai/legal/virginia">Are peptides legal in Virginia?</a>, PeptideAgent, updated September 22, 2026.